Best of the Blog: IN VIVO, February 2008

01 Mar 2008

Best of the Blog is a monthly column highlighting the best of our online content at www.windhover.com/blog. In February, Windhover's staff posted 52 articles to the site, covering biopharma, device and diagnostics R&D, business development, regulatory, and commercial news.

Best of the Blog is a monthly column highlighting the best of our free online content at The IN VIVO Blog, www.windhover.com/blog. In February, Windhover’s editorial staff posted 52 articles to the site, covering biopharma, device and diagnostics R&D, business development, regulatory, and commercial news. Last month we posted on the ongoing heparin debacle, introduced a loss-of-exclusivity inspired Wacky World of Generics series, and continued to provide weekly wrap-ups of the best in dealmaking. Here are a few of our favorite blog posts from February.

The numbers are in, and it’s not a pretty picture.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Wide Of The Mark: ‘The Worst EU Medtech Predictions Have Not Come True’

19 Jun 2025

• By Ashley Yeo

Jana Grieb, European regulatory and market access legal expert at McDermott Will & Emery, explains why the healthtech and pharma industries are warming to the new EU health commissioner as he faces calls to make the MDR more “user friendly.”

This Belgian Biotech’s Drug Cocktail Could Help Reverse Muscle Aging

18 Jun 2025

• By Jo Shorthouse

While big pharma pours billions into creating new anti-aging molecules, a Belgian startup has taken a different path: combining existing safe drugs with AI precision. The early results suggest it might be onto something revolutionary.

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist